Phase 3 trial of pixantrone plus rituximab versus gemcitabine plus rituximab in treating relapsed/refractory transplant-ineligible aggressive non-Hodgkin's lymphoma
Georgiev, P.G., Belada, D., Dakhil, S., Inhorn, L.F., Andorsky, D., Liberati, A.M., Beck, J.T., Quick, D., Patti, C., Sivcheva, L., Zaucha, J.M., Pettengell, R., Devries, T., Dean, J.P., Pavlyuk, M., Failloux, N., Hübel, K.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article